441 related articles for article (PubMed ID: 6993446)
21. A controlled clinical trial of alprazolam for the treatment of anxiety.
Rickels K; Csanalosi I; Greisman P; Cohen D; Werblowsky J; Ross HA; Harris H
Am J Psychiatry; 1983 Jan; 140(1):82-5. PubMed ID: 6128927
[TBL] [Abstract][Full Text] [Related]
22. Diazepam versus alprazolam for the treatment of panic disorder.
Noyes R; Burrows GD; Reich JH; Judd FK; Garvey MJ; Norman TR; Cook BL; Marriott P
J Clin Psychiatry; 1996 Aug; 57(8):349-55. PubMed ID: 8752017
[TBL] [Abstract][Full Text] [Related]
23. [Evaluation of the usefulness and effectiveness of anxiolytic therapies in neoplastic diseases].
Ziółko E; Knopik J; Bucior J; Foltyn W; Jastrzebska-Okoń K; Tomczyk A; Kempiński M
Pol Merkur Lekarski; 2004 Jun; 16(96):561-4. PubMed ID: 15510897
[TBL] [Abstract][Full Text] [Related]
24. Alprazolam in clinically anxious patients with depressed mood.
Aden GC
J Clin Psychiatry; 1983 Jan; 44(1):22-4. PubMed ID: 6130082
[TBL] [Abstract][Full Text] [Related]
25. Comparative study of the psychomotor and antistress effects of ritanserin, alprazolam and diazepam in healthy subjects: some trait anxiety-independent responses.
Danjou P; Warot D; Hergueta T; Lacomblez L; Bouhours P; Puech AJ
Int Clin Psychopharmacol; 1992 Nov; 7(2):73-9. PubMed ID: 1487624
[TBL] [Abstract][Full Text] [Related]
26. A double-blind comparison of buspirone and diazepam in outpatients with generalized anxiety disorder.
Feighner JP; Merideth CH; Hendrickson GA
J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):103-8. PubMed ID: 6130066
[TBL] [Abstract][Full Text] [Related]
27. A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder. Abecarnil Work Group.
Lydiard RB; Ballenger JC; Rickels K
J Clin Psychiatry; 1997; 58 Suppl 11():11-8. PubMed ID: 9363043
[TBL] [Abstract][Full Text] [Related]
28. Mianserin in the treatment of depressive illness and anxiety states in general practice.
Murphy JE
Br J Clin Pharmacol; 1978; 5 Suppl 1(Suppl 1):81S-85S. PubMed ID: 341949
[TBL] [Abstract][Full Text] [Related]
29. [Alprazolam (Tafil) and bromazepam (Lexotan) in the treatment of anxiety. A randomized, double-blind comparison in psychiatric outpatients].
Sonne LM; Bruun-Hansen J
Ugeskr Laeger; 1986 Jun; 148(23):1392-5. PubMed ID: 2873673
[No Abstract] [Full Text] [Related]
30. A double-blind comparative study of alprazolam and dothiepin hydrochloride in the treatment of anxiety associated with depression.
Cropper M; Garner A; McEwan GD; Munt DF; Rushbrook LA; Stevens V; Baker AC
Pharmatherapeutica; 1987; 5(2):76-82. PubMed ID: 3310018
[TBL] [Abstract][Full Text] [Related]
31. Treatment of premenstrual syndrome with alprazolam: results of a double-blind, placebo-controlled, randomized crossover clinical trial.
Smith S; Rinehart JS; Ruddock VE; Schiff I
Obstet Gynecol; 1987 Jul; 70(1):37-43. PubMed ID: 3299178
[TBL] [Abstract][Full Text] [Related]
32. Withdrawal reaction after long-term therapeutic use of benzodiazepines.
Busto U; Sellers EM; Naranjo CA; Cappell H; Sanchez-Craig M; Sykora K
N Engl J Med; 1986 Oct; 315(14):854-9. PubMed ID: 3092053
[TBL] [Abstract][Full Text] [Related]
33. Recent advances in anxiolytic therapy.
Rickels K
J Clin Psychiatry; 1981 Nov; 42(11 Pt 2):40-4. PubMed ID: 6120938
[No Abstract] [Full Text] [Related]
34. Relapse and rebound following discontinuation of benzodiazepine treatment of panic attacks: alprazolam versus diazepam.
Roy-Byrne PP; Dager SR; Cowley DS; Vitaliano P; Dunner DL
Am J Psychiatry; 1989 Jul; 146(7):860-5. PubMed ID: 2742010
[TBL] [Abstract][Full Text] [Related]
35. Alprazolam, diazepam, imipramine, and placebo in outpatients with major depression.
Rickels K; Chung HR; Csanalosi IB; Hurowitz AM; London J; Wiseman K; Kaplan M; Amsterdam JD
Arch Gen Psychiatry; 1987 Oct; 44(10):862-6. PubMed ID: 3310952
[TBL] [Abstract][Full Text] [Related]
36. Effects of diazepam on phobic avoidance behavior and phobic anxiety.
Whitehead WE; Blackwell B; Robinson A
Biol Psychiatry; 1978 Feb; 13(1):59-64. PubMed ID: 341998
[TBL] [Abstract][Full Text] [Related]
37. Alprazolam: a review of its pharmacodynamic properties and efficacy in the treatment of anxiety and depression.
Dawson GW; Jue SG; Brogden RN
Drugs; 1984 Feb; 27(2):132-47. PubMed ID: 6141930
[TBL] [Abstract][Full Text] [Related]
38. A comparison of alprazolam, gefarnate and their combination in treatment of peptic ulcer patients--an application of life table analysis.
Ogawa N; Namiki M; Kusunoki T; Fujii S
Int J Clin Pharmacol Ther Toxicol; 1985 Feb; 23(2):109-11. PubMed ID: 2859256
[TBL] [Abstract][Full Text] [Related]
39. Treatment of anxiety using fenobam (a nonbenzodiazepine) in a double-blind standard (diazepam) placebo-controlled study.
Pecknold JC; McClure DJ; Appeltauer L; Wrzesinski L; Allan T
J Clin Psychopharmacol; 1982 Apr; 2(2):129-33. PubMed ID: 7042771
[No Abstract] [Full Text] [Related]
40. Doxepin or diazepam for anxious and anxious-depressed outpatients?
Haskell DS; Gambill JD; Gardos G; McNair DM; Fisher S
J Clin Psychiatry; 1978 Feb; 39(2):135-9. PubMed ID: 344303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
